These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 1086325

  • 1. Reversal of cell surface abnormalities of T lymphocytes in hodgkin's disease after in vitro incubation in fetal sera.
    Fuks Z, Strober S, King DP, Kaplan HS.
    J Immunol; 1976 Oct; 117(4):1331-5. PubMed ID: 1086325
    [Abstract] [Full Text] [Related]

  • 2. [Cellular immunity in patients with Hodgkin's disease: modification induced by incubating lymphocytes with fetal calf serum and Hodgkin's serum].
    Rambotti P, Velardi A, Spinozzi F, Falini B, Martelli MF.
    Boll Ist Sieroter Milan; 1979 Mar 31; 58(1):90-9. PubMed ID: 552840
    [Abstract] [Full Text] [Related]

  • 3. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
    Fuks Z, Strober S, Kaplan HS.
    N Engl J Med; 1976 Dec 02; 295(23):1273-8. PubMed ID: 185517
    [Abstract] [Full Text] [Related]

  • 4. [T and B lymphocytes in chronic lymphocytic leukemia and Hodgkin's disease. Electron microscopic and immunologic studies].
    Cohnen G.
    Veroff Pathol; 1975 Dec 02; (0):1-99. PubMed ID: 49138
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Heterogeneity of human T lymphocytes to bind sheep erythrocytes and mitogenic responses of their subpopulations.
    Sasaki M, Sekizawa T, Takahashi H, Abo T, Kumagai K.
    J Immunol; 1975 Dec 02; 115(6):1509-14. PubMed ID: 1081102
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections.
    Chisari FV, Routenberg JA, Edgington TS.
    J Clin Invest; 1976 May 02; 57(5):1227-38. PubMed ID: 1083396
    [Abstract] [Full Text] [Related]

  • 9. E-rosette inhibiting substance in Hodgkin's disease spleen extracts.
    Bieber MM, Fuks Z, Kaplan HS.
    Clin Exp Immunol; 1977 Sep 02; 29(3):369-75. PubMed ID: 201408
    [Abstract] [Full Text] [Related]

  • 10. PHA dose dependent defect in lymphocyte stimulation and E-rosette-forming cells in untreated Hodgkin's disease.
    Land JM, Litwin J, Bigel P, Oberling F, Mayer S.
    Acta Haematol Pol; 1977 Sep 02; 8(2):131-4. PubMed ID: 329629
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cytotoxic activity of lymphocytes from patients with Hodgkin's disease.
    Holm G, Björkholm M, Mellstedt H, Johansson B.
    Clin Exp Immunol; 1975 Sep 02; 21(3):376-83. PubMed ID: 1081933
    [Abstract] [Full Text] [Related]

  • 13. [Case of implantation of human fetal thymus on the immunological reactivity in patients with Hodgkin's disease].
    Pekić B, Dujić A, Radojicić B, Radojicić C, Kolasinović N, Martinović N, Susaković N, Radovanović L.
    Bilt Hematol Transfuz; 1975 Sep 02; 3(1-2):105-19. PubMed ID: 1225309
    [Abstract] [Full Text] [Related]

  • 14. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM, Bigel P, Oberling F, Mayer S.
    Pathol Biol (Paris); 1978 Sep 02; 26(3-4):159-62. PubMed ID: 355984
    [Abstract] [Full Text] [Related]

  • 15. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM, Bigel P, Oberling F, Mayer S.
    Sem Hop; 1978 Sep 02; 54(37-40):1155-8. PubMed ID: 217096
    [Abstract] [Full Text] [Related]

  • 16. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
    Pappas A, Pees H, Girmann G.
    Z Immunitatsforsch Immunobiol; 1977 Apr 02; 153(1):1-10. PubMed ID: 868205
    [Abstract] [Full Text] [Related]

  • 17. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease.
    Zółtowska A, Arendt M, Gan J.
    Arch Immunol Ther Exp (Warsz); 1984 Apr 02; 32(1):51-7. PubMed ID: 6332594
    [Abstract] [Full Text] [Related]

  • 18. [Inhibitory action of Hodgkin's disease patients serum on T lymphocytes E rosette forming ability (author's transl)].
    Panteghini M, Piccioli E, Migliorati T, Ruggeri G.
    Ann Sclavo; 1979 Apr 02; 21(4):483-93. PubMed ID: 317987
    [Abstract] [Full Text] [Related]

  • 19. Studies of cell subpopulations mediating mitogen hyporesponsiveness in patients with Hodgkin's disease.
    Sibbitt WL, Bankhurst AD, Williams RC.
    J Clin Invest; 1978 Jan 02; 61(1):55-63. PubMed ID: 304068
    [Abstract] [Full Text] [Related]

  • 20. [The target cell for antilymphocyte antibodies in Hodgkin's disease].
    Del Giacco GS, Manconi PE, Tognella S, Mantovani G, Turno R, Grifoni V.
    Boll Ist Sieroter Milan; 1974 Jan 02; 53(4):562-4. PubMed ID: 4615725
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.